CNMD FY 2014 Earnings Report — CONMED Corporation Revenue & Financial Results | Market Cap Arena

CONMED CorporationCNMD

FY 2014 Earnings

Reported February 23, 2015

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2014	Prior Q	FY 2013	QoQ Change	YoY Change
Revenue	$734M	—	$757M	—	-2.9%
Op. Income	$53M	—	$57M	—	-6.6%
Gross Margin	54.3%	—	53.7%	—	0.5pp
Net Margin	4.4%	—	4.7%	—	-0.4pp
EPS (Diluted)	$1.16	—	$1.28	—	-9.4%
Free Cash Flow	$50M	—	$63M	—	-20.4%

Revenue Flow

Item	Amount
REVENUE	$734M
Cost of Revenue	$336M
GROSS PROFIT	$398M
R&D Expenses	$28M
Selling & Marketing	$0
General & Administrative	$294M
SG&A Expenses	$294M
Other Expenses	$7M
Operating Expenses	$346M
Cost & Expenses	$682M
OPERATING INCOME	$53M
Interest Income	$0
Interest Expense	$6M
Other Income/Expenses	-$6M
INCOME BEFORE TAX	$47M
Income Tax Expense	$14M
Net Income from Continuing Ops	$32M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$32M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$32M
D&A	$46M
EBIT	$53M
EBITDA	$99M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$734M
Cost of Revenue	$336M
GROSS PROFIT	$398M
R&D Expenses	$28M
Selling & Marketing	$0
General & Administrative	$294M
SG&A Expenses	$294M
Other Expenses	$7M
Operating Expenses	$346M
Cost & Expenses	$682M
OPERATING INCOME	$53M
Interest Income	$0
Interest Expense	$6M
Other Income/Expenses	-$6M
INCOME BEFORE TAX	$47M
Income Tax Expense	$14M
Net Income from Continuing Ops	$32M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$32M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$32M
D&A	$46M
EBIT	$53M
EBITDA	$99M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$32M
Depreciation & Amortization	$46M
Stock-Based Compensation	$9M
Deferred Income Tax	-$284.0K
Other Non-Cash Items	$1M
Change in Working Capital	-$22M
OPERATING CASH FLOW	$65M
Capital Expenditure	-$15M
Acquisitions (Net)	-$5M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$0
NET CASH FROM INVESTING	-$21M
Net Debt Issuance	$26M
Common Stock Repurchased	-$17M
Common Dividends Paid	-$22M
Other Financing Activities	-$13M
NET CASH FROM FINANCING	-$26M
FREE CASH FLOW	$50M
Net Change in Cash	$12M

Balance Sheet

Item	Amount
Cash & Equivalents	$66M
Short-Term Investments	$0
Net Receivables	$130M
Inventory	$148M
Other Current Assets	$14M
TOTAL CURRENT ASSETS	$381M
PP&E (Net)	$133M
Goodwill	$256M
Intangible Assets	$316M
Long-Term Investments	$0
Tax Assets	$1M
Other Non-Current Assets	$10M
TOTAL NON-CURRENT ASSETS	$717M
TOTAL ASSETS	$1.1B
Account Payables	$24M
Short-Term Debt	$1M
Deferred Revenue	-$24M
Other Current Liabilities	$55M
TOTAL CURRENT LIABILITIES	$116M
Long-Term Debt	$240M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$112M
Other Non-Current Liabilities	$49M
TOTAL NON-CURRENT LIABILITIES	$401M
TOTAL LIABILITIES	$517M
Common Stock	$215M
Additional Paid-In Capital	$320M
Retained Earnings	$406M
Treasury Stock	-$105M
Accum. Other Comp. Income	-$40M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$581M
Minority Interest	$0
TOTAL EQUITY	$581M
TOTAL LIABILITIES & EQUITY	$1.1B
Total Debt	$241M
Net Debt	$175M